Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
• Bernstein SocGen Group Upgrades Wayfair (W) to Outperform